Corticosteroid Dosing and Glucose Levels in COPD Patients Are Not Associated with Increased Readmissions

McGraw, Meghan; White, Heath; Zolfaghari, Kiumars; Hochhalter, Angela K.; Arroliga, Alejandro C.; Boethel, Carl

doi:10.15326/jcopdf.2020.0172

Cited by 1 publication

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The average glucose levels reported are similar to other published reports in diabetics and non‐diabetics with AECOPD 21 . While the glycemic improvements reported herein may seem pedestrian, it is important to recognize that the original study was a proof‐of‐concept project powered for changes in steroid dosing 12 .…”

Section: Discussionsupporting

confidence: 85%

“…5,20 The average glucose levels reported are similar to other published reports in diabetics and non-diabetics with AECOPD. 21 While the glycemic improvements reported herein may seem pedestrian, it is important to recognize that the original study was a proof-of-concept project powered for changes in steroid dosing. 12 Although these patients were not randomly selected for the posthoc analysis, it should be noted that the primary outcome found would require n = 398 patients to achieve the power of 80%; therefore, a larger enrollment capacity would be needed.…”

Section: Discussionmentioning

confidence: 96%

See 1 more Smart Citation

Effects of steroid stewardship on glycemic control in acute exacerbations of chronic obstructive pulmonary disease patients

Cole

2023

Clinical Respiratory J

View full text Add to dashboard Cite

Introduction The adverse effects of corticosteroids are dose‐dependent, and guidance is to use the lowest effective dose in most disease states. The study facility recently reported a steroid stewardship program that reduced steroid dosing in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients by 50%. The purpose of this post‐hoc analysis was to evaluate the effect of this intervention on glycemic control in hospitalized AECOPD before and after cohorts. Methods This was a retrospective post‐hoc review of hospitalized patients in a before and after study design (n = 27 in each group). The primary endpoint was the proportion of glucose readings >180 mg/dL. Baseline characteristics, mean glucose levels, and corrective insulin were also collected. Continuous variables were compared with a Student's t‐test (or Mann–Whitney U where appropriate) and nominal variables with a chi‐square test in R Studio. Results There was a significantly higher proportion of glucose >180 mg/dL readings in the pre‐intervention cohort: 38% vs. 25% (p = 0.007). The mean glucose levels were numerically lower post‐intervention but did not reach statistical significance (160 mg/dL vs. 145 mg/dL, p = 0.27) both in diabetics (192 mg/dL vs. 181 mg/dl, p = 0.69) and non‐diabetics (142 mg/dL vs. 125 mg/dL, p = 0.08). The use of correctional insulin was similar: a median of 25 units vs. 24.5 units (p = 0.92). Conclusion A stewardship program focused on steroid reduction in AECOPD significantly lowered the proportion of hyperglycemic readings but did not significantly affect mean glucose and corrective insulin usage while hospitalized.

show abstract

Section: Discussionsupporting

confidence: 85%